Christophe Klein

Inserm — France

Medicine · Health Sciences

50h-index13.4kcitations241works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(53), Immunotherapy and Immune Responses(49), Radiomics and Machine Learning in Medical Imaging(29), Cell Adhesion Molecules Research(24), Immune Cell Function and Interaction(23)

Publications240 total

Intratumour ploidy heterogeneity and clonal evolution in hepatocellular carcinoma
Journal of Hepatology·2025· 1 citedOpen Access
Laser-activated nanoparticles rewire tumor microenvironment enhancing PD-1 blockade and T cell response in cholangiocarcinoma
Hepatology·2025· 5 cited
Proximity Extension Assay identifies new targets of grey matter pathology in multiple sclerosis
Multiple Sclerosis and Related Disorders·2025Open Access
Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma
Cell Reports Medicine·2025· 4 citedOpen Access
Evaluation of Environmental <scp>DNA</scp> as a Surveillance Tool for Invasive House Mice (<i>Mus musculus</i>)
Environmental DNA·2025· 4 citedOpen Access
Advancement of Techniques for Precise Visualization and Quantification of Tertiary Lymphoid Structure-Associated Immune Cells in Tissue Samples
Methods in molecular biology·2024· 1 cited
A novel transgenic mouse model highlights molecular disruptions involved in the pathogenesis of Dent disease 1
Gene·2024· 4 cited
Data from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Data from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Figure S1 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Table S4 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Table S7 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Table S5 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Table S7 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Table S1 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Table S2 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Table S3 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Figure S1 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Table S6 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
Supplementary Figure S2 from Spatial Profiling of Ovarian Carcinoma and Tumor Microenvironment Evolution under Neoadjuvant Chemotherapy
2024Open Access
page 1 of 12Next →

Frequent Co-authors

Guido Kroemer(4), Laurence Zitvogel(4), Qinghe Zeng(4), Stefano Caruso(4), Hélène Regnault(4), Nicolas Loménie(4), Julien Caldéraro(4), Francine Béhar‐Cohen(4), Connie P.M. Duong(3), Romain Daillère(3), Paule Opolon(3), Gladys Ferrere(3), Alexander Eggermont(3), T Steinmayer(3), Roland Kaufmann(3), Marie‐Christine Naud(3), Pascale Maillé(3), Narmin Ghaffari Laleh(3), Jean–Michel Pawlotsky(3), Jakob Nikolas Kather(3)